Psychopharmacologic Drugs Advisory Committee Roster
Applying for Membership on FDA Advisory Committees
As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)
The committee consists of a core of 9 voting members.
Chairperson
Vacant
Designated Federal Officer
Joyce Frimpong, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: PDAC@fda.hhs.gov
+ Michelle Baladi, PhD
Expertise: Neuropsychiatry
Term: 2/15/2024 – 10/31/2027
Executive Director, Clinical Development Neuroscience
Jazz Pharmaceuticals
3170 Porter Drive
Palo Alto, California, 94304
**Carla M. Canuso, MD
Expertise: Neuropsychiatry
Term: 2/15/2024 –10/31/2027
Vice President, Head of Neuropsychiatry Clinical Development
Janssen Research and Development, LLC
1125 Trenton-Harbourton Road
Titusville, New Jersey, 08560
Patrick S. Thomas, Jr., MD, PhD
Expertise: Psychiatry
Term: 8/30/2022 – 6/30/2026
Assistant Professor
Department of Psychiatry
Baylor College of Medicine, Menninger Clinic
12301 S. Main Street
Houston, Texas 77035
*Consumer Representative (vacant)
** Industry Representative (non-voting)
+ Alternative Industry Representative (non-voting)